Gates Package — page 26
of 1375 pages
← p.25 p.27 → · this page in the original PDF · package
In vitro antiviral activity of favipiravir against EBOV
2) Post-exposure efficacy of oral T-705 (Favipiravir)
against inhalational Ebola virus infection
in
a mouse model.
1) Successful treatment of advanced Ebola virus
infection with T-705 (favipiravir) in
a small animal model
Oestereich L et al. Antiviral Res. 2014 105:17-21.
Smither SJ et al. Antiviral Res. 2014 104:153-155.
ICs = 10.5 pg/ml
ICgg = 29 pg/ml
- EBOV E718, Kikwit
- Zaire EBOV Mayinga 1976
- Vero C1008 cells
- Vero E6 cells
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/26
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:exh:00014 | — | attachment | 26 |
| gates:email:00005 | 2014-09-17 | 20–26 |